Literature DB >> 12681505

Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells.

Sandra M Sacre1, Anita K Stannard, James S Owen.   

Abstract

Although apolipoprotein E3 (apoE3) is atheroprotective, two common isoforms, apoE2 and apoE4, produce recessive and dominant hyperlipidaemias, respectively. Using a fluorescent assay, we report herein that apoE3 particles secreted from recombinant cells stimulate more nitric oxide release in cultured human EA.hy926 endothelial cells than apoE2 or apoE4 (141% more than controls vs. 61 or 11%). Phosphatidylinositol (PI) 3-kinase inhibitors suppressed the apoE effect, while apoE receptor 2 (apoER2) was tyrosine phosphorylated. We conclude that apoE stimulates endothelial nitric oxide release in an isoform-dependent manner, and propose that tyrosine phosphorylation of apoER2 initiates PI3-kinase signalling and activation of nitric oxide synthase. Copyright 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681505     DOI: 10.1016/s0014-5793(03)00261-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

2.  Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier Stabilization.

Authors:  Ranjeet K Sinha; Xia V Yang; José A Fernández; Xiao Xu; Laurent O Mosnier; John H Griffin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

Review 3.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 4.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

5.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

6.  Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.

Authors:  Meaghan D Waltmann; Joshua E Basford; Eddy S Konaniah; Neal L Weintraub; David Y Hui
Journal:  Biochim Biophys Acta       Date:  2014-05-16

7.  Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress.

Authors:  James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui
Journal:  J Biol Chem       Date:  2012-06-23       Impact factor: 5.157

8.  Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.

Authors:  Yanjuan Zhu; Ahmer Kodvawala; David Y Hui
Journal:  Biochem J       Date:  2010-04-28       Impact factor: 3.857

9.  Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

Authors:  Sangeetha Ramesh; Craig N Morrell; Cristina Tarango; Gail D Thomas; Ivan S Yuhanna; Guillermina Girardi; Joachim Herz; Rolf T Urbanus; Philip G de Groot; Philip E Thorpe; Jane E Salmon; Philip W Shaul; Chieko Mineo
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

10.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.